Priority Date: 08.06.12 (US 201261657574P)

COMPOSTIONS AND METHODS FOR CANCER IMMUNOTHERAPY

  • Application ID: EP13799826
  • Status: EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Technology Company

Attorney

operating since 1890
Headquarter in London and 4 offices
active in Legal Services

Specialization

This patent has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) Mewburn Ellis LLP is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 08.06.2012 - Priority Date (US 201261657574P)
  • 12.12.2013 - Publication A1 (WO2013185052)
  • 15.04.2015 - Publication A1 (EP2858722)

IPC Classification